TCTMD1h
Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F
The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.
TCTMD3h
First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2
Clinicians typically first turn to antiarrhythmic drugs, but switching up the order may be offer patients better outcomes.
TCTMD8h
Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD
Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.
TCTMD22h
Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients
CHICAGO, IL—Giving rivaroxaban (Xarelto; Bayer/Janssen) to adults under the age of 65, after an atrial fibrillation (AF) ...
TCTMD22h
SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity
CHICAGO, IL—The weight-loss medication tirzepatide (Eli Lilly) significantly cut the risk of cardiovascular mortality and ...